Products
2681 products
Code | Description | Unit |
---|---|---|
EPY0001876 | Gadodiamide impurity A | EP-unit |
EPY0001877 | Gadodiamide impurity B | EP-unit |
EPG0049000 | Galactitol | EP unit |
EPG0050000 | Galactose | EP unit |
EPY0001279 | Galantamine hydrobromide | EP unit |
EPY0001190 | Galantamine natural for system suitability | EP unit |
EPY0001201 | Galantamine racemic mixture | EP unit |
EPY0001191 | Galantamine synthetic for system suitability | EP unit |
EPG0150000 | Gammacyclodextrin | EP unit |
EPY0001129 | Ganciclovir | EP unit |
EPY0001144 | Ganciclovir impurity mixture | EP unit |
EPY0001813 | Gefitinib | 100 mg |
EPY0001809 | Gefitinib for system suitability | 0,351 mg |
EPY0000675 | Gemcitabine hydrochloride | EP unit |
EPY0000676 | Gemcitabine impurity A - 4-aminopyrimidin-2(1H)-one (Cytosine) | EP unit |
EPY0001682 | Gemcitabine impurity C 2',2'-Difluoro-2'-deoxyuridine | EP unit |
EPY0000513 | Gemfibrozil | EP unit |
EPY0000514 | Gemfibrozil for system suitability | EP unit |
EPY0001835 | Geniposide | EP-unit |
EPY0001363 | Gentamicin for peak identification | EP unit |
EPG0200000 | Gentamicin sulphate | EP unit |
EPY0001112 | Gestodene | EP unit |
EPY0001110 | Gestodene for system suitability | EP unit |
EPY0001116 | Gestodene impurity I - 13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-20-yn-3-one | EP unit |
EPY0001012 | Ginkgo dry extract for peak identification | EP unit |
EPY0001010 | Ginkgolic Acid | EP unit |
EPY0001029 | Ginseng dry extract | EP unit |
EPY0001347 | Ginsenoside Rb1 | EP unit |
EPG0300000 | Gitoxin | EP unit |
EPG0325000 | Glibenclamide | EP unit |
EPY0001511 | Glibenclamide for peak identification | EP unit |
EPG0325010 | Glibenclamide impurity A - 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulphonamide | EP unit |
EPY0000242 | Glibenclamide impurity B - methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl] sulphonyl]carbamate | EP unit |
EPG0326000 | Gliclazide | EP unit |
EPG0326004 | Gliclazide impurity B - 2-nitroso-octahydrocyclopenta[c]pyrrole | EP unit |
EPG0326012 | Gliclazide impurity F - 1-(hexahydrocyclopenta[c]pyrrol-2-(1H)-yl-3-[(2-methylphenyl)sulphonyl]urea | EP unit |
EPY0000515 | Glimepiride | EP unit |
EPY0001742 | Glimepiride for impurity A identitication | EP unit |
EPY0000516 | Glimepiride for system suitability | EP unit |
EPG0340000 | Glipizide | EP unit |
EPG0342000 | Glipizide impurity A - 4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide | EP unit |
EPY0000523 | Glipizide impurity C - ethyl 2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl]carbamate | EP unit |
EPY0000643 | Glipizide impurity D - 6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide | EP unit |
EPY0001140 | Glipizide impurity mixture | EP unit |
EPY0001381 | Glucosamine for system suitability | EP unit |
EPY0001685 | Glucosamine sulfate potassium chloride | EP unit |
EPY0001407 | Glucosamine sulfate sodium chloride | EP unit |
EPG0350500 | Glucose (Dextrose) | EP unit |
EPY0001745 | Glucose monohydrate | EP unit |
EPG0355000 | Glutamic acid | EP unit |
EPY0000517 | Glutathione | EP unit |
EPG0400000 | Glycerol (85 per cent) - Reference Spectrum | EP unit |
EPY0001391 | Glycerol formal | EP unit |
EPY0000794 | Glycerol monocaprylate | EP unit |
EPY0000795 | Glycerol monocaprylocaprate | EP unit |
EPG0400006 | Glycerol monolinoleate | EP unit |
EPG0400007 | Glycerol mono-oleate | EP unit |
EPG0400008 | Glycerol monostearate 40-55 | EP unit |
EPG0400101 | Glyceryl trinitrate - Reference Spectrum | EP unit |
EPG0400100 | Glyceryl trinitrate solution | EP unit |
EPG0450000 | Glycine | EP unit |
EPY0001308 | Glycopyronium bromide | EP unit |
EPY0001309 | Glycopyrronium for peak identification | EP unit |
EPY0001358 | Glycopyrronium impurity N - (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium | EP unit |
EPG0525000 | Gonadorelin | EP unit |
EPY0000125 | Goserelin | EP unit |
EPY0001473 | Goserelin for NMR identification | EP unit |
EPY0000194 | Goserelin validation mixture | EP unit |
EPY0000126 | Gosereline - Reference Spectrum | EP unit |
EPG0550000 | Gramicidin | EP unit |
EPY0000396 | Granisetron hydrochloride | EP unit |
EPY0000477 | Granisetron impurity A - 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1] non-3-yl]-2H-indazole-3-carboxamide | EP unit |
EPY0000478 | Granisetron impurity B - N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide | EP unit |
EPY0000395 | Granisetron impurity E - (1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine | EP unit |
EPG0600000 | Griseofulvin | EP unit |
EPY0000619 | Guaiacol | EP unit |
EPG0700000 | Guaifenesin | EP unit |
EPY0000117 | Halofantrine hydrochloride | EP unit |
EPY0000118 | Halofantrine impurity C - [1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol | EP unit |
EPH0100000 | Haloperidol | EP unit |
EPH0100100 | Haloperidol decanoate | EP unit |
EPY0001518 | Haloperidol for peak identification | EP unit |
EPY0001517 | Haloperidol for system suitability | EP unit |
EPH0150000 | Halothane - Reference Spectrum | EP unit |
EPY0000673 | Harpagoside | EP unit |
EPY0001287 | Heparin calcium for NMR identification | EP unit |
EPY0001282 | Heparin for physio-chemical analysis | EP unit |
EPH0185000 | Heparin LMM for assay BRP | EP unit |
EPH0190000 | Heparin LMM for calibration Mn-3700 | EP unit |
EPH0200000 | Heparin sodium BRP | EP unit |
EPY0001283 | Heparin sodium for system suitability | EP unit |
EPY0001192 | Hepatitis A Vaccine (Inactivated, Non-Adsorbed) | EP unit |
EPH0205010 | Hepatitis A vaccine (inactivated,absorbed) Type B BRP | EP unit |
EPY0001624 | Hepatitis A virus Coating Reagent for ELISA - BRR | EP unit |
EPY0000389 | Hepatitis B vaccine (rDNA) BRP method A (thiomersal free) | EP unit |
EPH0210010 | Hepatitis B vaccine (rDNA) BRP method B | EP unit |
EPY0000063 | Heptaminol hydrochloride | EP unit |
EPY0000057 | Heptaminol impurity A - (2RS)-6-methylhept-5-en-2-amine | EP unit |
EPY0001203 | Hesperidin | EP unit |
EPH0330000 | Hexamidine diisetionate | EP unit |